The efficacy and safety of cyclosporine reduction in de novo renal allograft patients receiving sirolimus and corticosteroids: results from an open-label comparative study.
about
The efficacy and safety of cyclosporine reduction in de novo renal allograft patients receiving sirolimus and corticosteroids: results from an open-label comparative study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
The efficacy and safety of cyc ...... open-label comparative study.
@en
The efficacy and safety of cyc ...... open-label comparative study.
@nl
type
label
The efficacy and safety of cyc ...... open-label comparative study.
@en
The efficacy and safety of cyc ...... open-label comparative study.
@nl
prefLabel
The efficacy and safety of cyc ...... open-label comparative study.
@en
The efficacy and safety of cyc ...... open-label comparative study.
@nl
P2093
P2860
P356
P1476
The efficacy and safety of cyc ...... open-label comparative study.
@en
P2093
Anthony J Zygmunt
Domingo del Castillo
European Rapamune Cyclosporine Minimization Study Group
Ferdinand Mühlbacher
Hans-Helmut Neumayer
Klemens Budde
Sergio Stefoni
P2860
P304
P356
10.1111/TRI.12228
P577
2013-11-25T00:00:00Z